CurrentBlue Cross Blue Shield - MassachusettsPolicy 018

Balloon dilation of the Eustachian tube (BDET) — Coverage Criteria

Medical policy governing when balloon dilation of the eustachian tube is considered medically necessary or investigational for adult members of Blue Cross Blue Shield of Massachusetts across commercial and Medicare products.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyBalloon dilation of the Eustachian tube (BDET) — Coverage Criteria

Policy CodePolicy 018

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain precertification for inpatient BDET and document chronic signs/symptoms and required clinical criteria including supporting CPT and ICD-10 codes.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Adults (18+)age group specified for medically necessary BDET

69705/69706procedure codes listed

Inpatient PAprecertification requirement

RCTs & reviewsevidence sources cited

Coverage Criteria for Balloon Dilation of the Eustachian Tube (BDET)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

inv-01: Medically Necessary Indications for BDET

Covered when ALL of the following are met:

Age: Individual is an adult (18 years of age and older)>=18 years

Symptoms - baro/chronic effusion: Difficulty equilibrating pressure with baro-challenge OR history of negative middle ear pressure or middle ear effusion of 2–3 months duration

Symptom correlation: Hearing loss or aural fullness that is temporarily relieved by auto‑insufflation if the individual is capable of performing it

Medical management: Failure to respond to appropriate medical management of co‑occurring conditions (e.g., allergic rhinitis, rhinosinusitis, laryngopharyngeal reflux), including 4–6 weeks of a nasal steroid spray unless contraindicated4-6 weeks nasal steroid trial unless contraindicated

Tympanostomy history: If history of tympanostomy tube placement, symptoms should have improved while tubes were patent (a trial of tympanostomy tubes is not required prior to BDET)

Objective findings: Objective pathological findings on dynamic endoscopic examination of the eustachian tube OR, if no pathological findings are visible, history and physical remain consistent with obstruction within the cartilaginous eustachian tube

BDET is considered investigational when obstruction is located in the bony portion of the eustachian tube, when adenoids are the sole cause of obstruction, or when any of the following are present: history of carotid artery dehiscence, cystic fibrosis, craniofacial syndrome, acute tympanic membrane perforation, neoplasm causing extrinsic obstruction of the eustachian tube, history of persistent patulous eustachian tube, prior eustachian tube intervention, history of radiation therapy to the nasopharynx, systemic mucosal or immunodeficiency disease, or neuromuscular disorders causing hypotonia/ineffective eustachian tube opening when that disorder is the sole cause of the dysfunction.

Repeat balloon dilation of the eustachian tube (repeat BDET) is considered investigational.

Portions of the policy and determinations regarding investigational indications are based on expert opinion as noted in the policy endnotes.

BDET is considered investigational for all indications not specified as medically necessary, and procedures performed for investigational indications (including repeat procedures and the exclusions listed in this policy) may be subject to denial.

Provider Actions, Authorization, and Documentation

Prior Authorization

Prior Authorization Required

Prior authorization is required for services described in this policy when performed inpatient. For outpatient settings, prior authorization is generally not required for the products listed (Commercial PPO and Indemnity, Medicare HMO, Medicare PPO) but requirements may vary by product and should be confirmed with the payer.

Precertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient.
Outpatient prior authorization: Commercial PPO and Indemnity, Medicare HMO, Medicare PPO — prior authorization is not required per listed product notes; verify plan-specific rules.

Denial Risk

Precertification Requirement for Inpatient Services

Precertification is specifically required for inpatient procedures under this policy. Failure to obtain required precertification/preauthorization for inpatient admissions may result in denial or claim processing delays.

Precertification required for inpatient procedures.
Obtain authorization before inpatient admission to avoid denial risk.

Note

No Explicit Denial Triggers Specified

There are no explicit denial triggers listed in the policy excerpts provided. However, investigational indications and procedures performed without required inpatient precertification are called out elsewhere and may lead to denial.

Policy text identifies certain investigational indications and repeat BDET as investigational (see policy clinical sections).
No standalone explicit list of denial triggers is present in the provided sections.

Documentation Required

References and Policy Terms of Use

References and the Medical Policy Terms of Use apply to this policy and provide additional administrative and clinical guidance. Providers should consult the payer's Managed Care Guidelines, Clinical Exception Process, Indemnity/IPPQ Guidelines, and Medical Technology Assessment Guidelines linked in the policy for full terms and requirements.

Medical Policy Terms of Use and related guidelines (Managed Care Guidelines; Clinical Exception Process; Indemnity/IPPQ Guidelines; Medical Technology Assessment Guidelines) govern policy application.

Step Therapy

No Step Therapy Requirements Specified

No step therapy requirements are specified in the provided policy excerpts for BDET. Clinical criteria and prior medical management (e.g., 4–6 weeks of nasal steroid spray when appropriate) are described, but no formal step-therapy program is noted.

No step therapy rules specified for balloon dilation of the eustachian tube in the provided sections.
Clinical management expectations (e.g., trial of medical therapy) are described but do not constitute a step-therapy requirement.

Documentation Required

Clinical and Coding Documentation Expectations

Documentation should support medical necessity, including chronic signs/symptoms of eustachian tube obstruction, objective findings on dynamic endoscopic examination or consistent history/physical, prior response to tympanostomy tubes if applicable, and trials of appropriate medical management. Coding and diagnosis codes (CPT and ICD-10) should be submitted as indicated by the clinical criteria.

Support chronic signs/symptoms (e.g., baro-challenge difficulty, middle ear effusion ≥2–3 months, hearing loss or aural fullness relieved by auto-insufflation).
Document failure to respond to appropriate medical management (e.g., 4–6 weeks nasal steroid spray) unless contraindicated.
If prior tympanostomy tubes were placed, document improvement while tubes were patent; trial of tympanostomy tubes is not required prior to BDET.
Include appropriate CPT (69705, 69706) and ICD-10 diagnosis codes (H68.021, H68.022, H68.023, H69.81, H69.82, H69.83) to support medical necessity.

Definitions

Balloon dilation of the eustachian tube (BDET) — definition

Procedure descriptionTransnasal endoscopic intraluminal dilation of the cartilaginous portion of the eustachian tube using a saline-filled balloon catheter introduced through the nose, inflated and held under pressure (approximately two minutes) then deflated and removed.

Target anatomical siteCartilaginous portion of the eustachian tube (not the bony portion).

Mechanism of actionBalloon inflation crushes diseased epithelium and submucosal lymphoid hyperplasia, allowing healing with restoration of normal epithelium and improved tube patency.

Anesthesia/settingMay be performed under general anesthesia or under local office anesthesia.

Typical inflation durationPressure is maintained on the balloon for approximately two minutes during the procedure.

Eustachian tube dysfunction (ETD) — definition

Core definitionEustachian tube dysfunction (ETD) occurs when the functional valve of the eustachian tube fails to open and/or close properly, due to inflammation or anatomic abnormalities.

Common subtype and causesObstructive ETD (OETD) is most commonly caused by inflammation, including rhinosinusitis and allergic rhinitis.

Typical clinical symptomsMuffled hearing, ear fullness, tinnitus, and vertigo; chronic OETD can lead to hearing loss, otitis media, tympanic membrane perforation, and cholesteatoma.

Context in policy and literatureETD is the clinical condition addressed by the cited literature and consensus statements (eg, AAO-HNS clinical consensus statement) referenced in the policy.

OpenPayer

Balloon dilation of the Eustachian tube (BDET) — Coverage Criteria

Coverage Criteria for Balloon Dilation of the Eustachian Tube (BDET)

Coding

Provider Actions, Authorization, and Documentation

Background

Definitions

69705	Nasopharyngoscopy, surgical, with dilation of eustachian tube (ie, balloon dilation); unilateral.
69706	Nasopharyngoscopy, surgical, with dilation of eustachian tube (ie, balloon dilation); bilateral.

H68.021	Chronic Eustachian salpingitis, right ear.
H68.022	Chronic Eustachian salpingitis, left ear.
H68.023	Chronic Eustachian salpingitis, bilateral.
H69.81	Other specified disorders of Eustachian tube, right ear.
H69.82	Other specified disorders of Eustachian tube, left ear.
H69.83	Other specified disorders of Eustachian tube, bilateral.